Brief Skills for Safer Living (Brief-SfSL)
Investigating the Efficacy of a Novel Therapy for Suicide Risk in Adults: A Randomized Controlled Trial of an Intensive Single Session of "Brief Skills for Safer Living"
1 other identifier
interventional
150
1 country
1
Brief Summary
The goal of this project is to assess the efficacy of Brief-Skills for Safer Living (Brief-SfSL) in a randomized control trial. The investigators will be testing 150 participants Canada-wide, half of which will be randomized to receive Brief-SfSL (B-TAU) and the other half will be randomized to receive Brief-SfSL after a 3 month waitlist (WL-TAU). The main questions this study seeks to answer are:
- Is B-TAU more efficacious than WL-TAU for reducing suicidal thoughts at 3 months?
- Is B-TAU more efficacious than WL-TAU at 3 months for reducing depression severity, anxiety, and anhedonia?
- Is B-TAU more efficacious than WL-TAU at 3 months for improving social connectedness, emotional regulation, functioning (work, life, social), executive control and social problem-solving?
- Are adverse events equivalent between B-TAU and WL-TAU at 3 months?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2024
CompletedFirst Posted
Study publicly available on registry
August 26, 2024
CompletedStudy Start
First participant enrolled
November 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
January 22, 2026
November 1, 2025
2.9 years
August 16, 2024
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in suicidal ideation using Beck Scale for Suicide Ideation
Beck Scale for Suicide Ideation is a 21-item self-report scale that quantifies suicidal ideation. Items are scored 0 to 2 and yield a total score ranging from 0 to 38. Higher scores reflect greater severity of suicidal ideation.
From baseline to 3 months post-intervention
Secondary Outcomes (10)
Change in depression symptoms using the Quick Inventory of Depressive Symptoms 16-item scale (QIDS).
From baseline to 3 months post-intervention
Change in anxiety symptoms using the Generalized Anxiety Disorder 7-item scale (GAD-7)
From baseline to 3 months post-intervention
Changes in anhedonia using the Dimensional Anhedonia Rating Scale (DARS)
From baseline to 3 months post-intervention
Changes in feelings of social connectedness and burdensomeness using the Interpersonal Needs Questionnaire (INQ)
From baseline to 3 months post-intervention
Changes in work, social and family functioning using the Sheehan Disability Scale (SDS)
From baseline to 3 months post-intervention
- +5 more secondary outcomes
Study Arms (2)
Brief-SfSL (B-TAU)
EXPERIMENTALParticipants will receive the Brief-SfSL treatment within 1 week of their screening.
Wait List (WL-TAU)
NO INTERVENTIONParticipants will be put on a wait list and receive the Brief-SfSL treatment 3 months after their screening.
Interventions
Brief-SfSL is a single 90-minute intervention that that: 1. helps clients understand their suicide narrative, which explores the origin and meaning of their suicidal thoughts 2. builds specific skills to keep oneself safe from suicide even if suicidal thoughts are present 3. includes enhanced safety planning by identifying the barriers to enacting a safety plan and solutions to overcome them
Eligibility Criteria
You may qualify if:
- Suicidal ideation in the past week
- Access to a computer or phone with a camera
- Access to internet
- Access to an emergency contact and hospital within commuting distance
- Not receiving other psychotherapy/counselling services concurrently
- Willing to have the session recorded to determine therapy fidelity
- Any psychiatric diagnosis is allowed
- Follow-up visits with a psychiatrist and/or family doctor where a psychotherapeutic modality (e.g., Dialectical Behavioural Therapy, psychodynamic therapy, etc.) is not being used are allowable
You may not qualify if:
- Inability to undergo psychotherapy in English
- Presence of cognitive impairment that would limit consent and understanding of Brief Skills for Safer Living
- Active psychosis
- Unwilling or unable to provide informed consent
- Previously enrolled in the Brief-SfSL pilot study
- Unwilling or unable to communicate verbally
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Michael's Hospital
Toronto, Ontario, M5B 1M8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sakina Rizvi, PhD, MACP
Unity Health Toronto
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2024
First Posted
August 26, 2024
Study Start
November 17, 2025
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
January 22, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share